Nov 5, 2014
Blueprint for new IITs and NITs likely to roll out today
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 28, 2014
India Projected to Become Third-biggest Aviation Market by 2031
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
IMF issues warning on slower economic growth in 2014 and 2015
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
USINPAC releases #US-#India ‘Business Barometer’
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
More than half of U.S. unlikely to do business in India: study
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
More than half of US unlikely to do business in India: Reports
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
US lawmakers forge ahead to set US-India relations on new course
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 6, 2014
New MoU to be signed between India and the USA gets nod from the Indian Cabinet
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Sep 30, 2014
India set to become a founding partner in the Thirty Meter Telescope Project in Pacific Ocean
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Sep 30, 2014
Global Initiative of Academic Networks approved by the Indian HRD Ministry
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Sep 23, 2014
Narendra Modi will build new IIT in Goa aided by US institutions
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Aug 28, 2014
Turning Point in Bilateral Relations: US Medical Delegation to India arrives
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Aug 26, 2014
Indian American author Nina McConigley wins PEN Open Book Award
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Aug 26, 2014
Indian-American educator Pradeep Khosla to help India with hospital management
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Aug 26, 2014
India-US natural partners: US diplomat
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
View All

University of Pune with Serum Institute complete animal study on herbal vaccine, adjuvants

Source : PhramaBiz.com
June 04, 2012

 

Date: 4th June 2012

University of Pune’s Interdisciplinary School of Health Sciences and Serum Institute of India, in a collaborative research programme, have completed animal study on herbal vaccine, adjuvants. The project was supported by Department of Science and Technology. In another study, the Pune University along with US-based BioVed Pharmaceuticals Inc. went on to research on blood disorder properties in cancer bearing animals which is ready for commercialization.

Many new sub-unit vaccines require effective adjuvants to increase immune response and vaccine efficacy. Present adjuvants have some limitations and so the industry needs newer agents. “We developed herbal vaccine adjuvants, which may be safer and economical, Professor Bhushan Patwardhan, presently vice chancellor, Symbiosis International University and former professor, University of Pune told Pharmabiz.

The objective of the research was to understand cell protection. Serum Institute will continue for possible commercialization, he added.

Under the cancer research project in collaboration with BioVed Pharmaceuticals Inc., led by Dr Deepa Chitre, the University used chemotherapy drugs meant for lymphomas, leukaemia, lung cancer and breast cancer to screen plant-derived drugs to prevent myelo-suppression which can lead reduction in blood cells, skin texture damage and hair fall.

The study was done on activity-related extractions to identify best performing candidate for cancer drugs. One US patent is filed in the area of cancer adjuvants. This product will have significant importance in cancer therapeutics, especially to counter untoward effects of chemotherapy without compromising the anticancer activity, said Prof. Patwardhan.

The University also studied the pharmacodynamics of ashwagandha, shatavari and guduchi in experimentally induced tumours and infection mouse models, where one well-recognized cellular target for immunomodulation was Th1–Th2 balance, he added.

The findings are published as a part of research account of Dr Patwardhan covering three decades research on evidence based Ayurveda in the latest issue of Current Science Volume 102 No 10, issue dated May 25, 2012.

“Ayurveda allows drug researchers to start from time-tested and safe botanical material. The normal drug discovery course of ‘laboratory to clinics’ becomes ‘clinics to laboratories’ which is a ‘reverse pharmacology’ approach where safety is an important starting point and efficacy is a matter of validation,” stated Dr Patwardhan.

The database of Ayurveda provides information on botanicals that can best be used as single drugs in natural or processed form. It gives a range of multi-ingredient combinations from simple mixtures to complex processed dosage forms. Modern medicine uses target based single drugs, which have the distinct advantage of known pharmacokinetics, dynamics and precise dose response relationships. However, recent trends indicate use of multi-target approach, particularly in the treatment of difficult- to-treat chronic diseases such as diabetes, asthma, hypertension, cancer, arthritis and the like. “Our work has helped establish the pharmaco-epidemiological evidence base through systematic documentation and analysis. We have also addressed quality control and regulatory issues relevant to botanical drugs,” he said.

In the future, modern medicine could be based on such ancient time-tested remedies, developed using advanced technologies from the West. Traditional medicine-inspired drug discovery and development is therefore considered to be an efficient, faster and affordable strategy, said Dr Patwardhan.

 
 
 
 
 

 


  • AUSIB joins Nagpur First as Supporting Partners for Annual Global Nagpur Summit 2015
    read more...
  • Events and Delegations between India and The United States
  • Edwin Burkett
  • James mancuso
  • Gerald V quinnan
  • Mark evans
  • Rahul jindal
  • Rahul jindal
^ Back to Top